LYCOS RETRIEVER Beta Retriever Home  |  What is Lycos Retriever?   
Tort Reform
built 642 days ago
The agenda for this particular so-called "tort reform" is solely for the insurance industry. There is no requirement for how insurance companies calculate premiums. And if the industry were in danger of collapsing, how could they afford the billions of dollars in lobbying and campaign contributions and multi-millian dollar annual salaries. And what of the rampant and systemic corruptions embedded into the industry practices which Attorney General of New York, Elliot Spitzer is only beginning to reveal. Huge corruptions. Huge dollars.
Source:
Thompson didn’t oppose all types of tort reform, as some outlets have reported. When President Clinton vetoed the Securities Litigation Reform Act, Thompson voted to override the veto. (John McCain voted with Clinton.) After Sept. 11, he voted to protect businessmen from liability for terrorist attacks. And he voted for class-action reform, too.
In addition, according to Schaefer, tort reform is designed to rein in the tendency of judges to regulate rather than judge. "A lot of what's gone on in the judicial system is regulation, which is the job of regulators and the legislature, not the judiciary," she says. "Regulation is not the proper role of the judicial system."
Source:
The president's visit to Madison County was one of several events this week to win congressional and public support for tort reform. He faces strong opposition from Democrats in Congress, who say patients deserve the right to seek awards, without arbitrary ceilings, for medical mistakes.
Source:
Congressman Conyers has taken a leading role in fighting against unfair tort reform proposals. Regarding medical malpractice, the Congressman has worked tirelessly to champion patients' rights while addressing the rising costs of medical malpractice insurance premium.
Source:
Follow the money for this study: tort reform group Pacific Research Institute (PRI) funds CMPI, which shares an executive with a PR firm that represents major pharmaceutical manufacturers. It's no surprise that the big drug-makers are trying to buy studies to avoid responsibility for their drugs that have harmed people.
SEARCH
MORE ABOUT
  Tort Reform